These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34556625)

  • 21. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of skin melanoma in Gran Canaria (Canary Islands, Spain) is lower than expected in Southern Europe despite high-risk environmental conditions: an island-wide cross-sectional study.
    Grau-Pérez M; Carretero G; Almeida P; Castro-González E; de-la-Rosa-Del-Rey MDP; González-Martín JM; Borrego L
    Cancer Causes Control; 2021 May; 32(5):525-535. PubMed ID: 33646461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia.
    Wong CL; Bansback N; Lee PE; Anis AH
    Can J Neurol Sci; 2009 Nov; 36(6):735-9. PubMed ID: 19960752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of specific drugs for Alzheimer's disease].
    Villar Fernández I; Rabaneque Hernández MJ; Armesto Gómez J; García Arilla E; Izuel Rami M
    Neurologia; 2007 Jun; 22(5):275-84. PubMed ID: 17508301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
    Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
    J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Drug Prescription Rates for Dementia: An Observational Population-Based Study in France, 2006-2014.
    François M; Sicsic J; Elbaz A; Pelletier Fleury N
    Drugs Aging; 2017 Sep; 34(9):711-721. PubMed ID: 28752503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Régie de l'Assurance Maladie du Québec database.
    Lachaine J; Beauchemin C; Crochard A; Bineau S
    Can J Psychiatry; 2013 Apr; 58(4):195-200. PubMed ID: 23547642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the problem of type 2 diabetes-related mortality in the Canary Islands, Spain. The DARIOS Study.
    Marcelino-Rodríguez I; Elosua R; Pérez Mdel C; Fernández-Bergés D; Guembe MJ; Alonso TV; Félix FJ; González DA; Ortiz-Marrón H; Rigo F; Lapetra J; Gavrila D; Segura A; Fitó M; Peñafiel J; Marrugat J; de León AC
    Diabetes Res Clin Pract; 2016 Jan; 111():74-82. PubMed ID: 26546396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based study of dosing and persistence with anti-dementia medications.
    Brewer L; Bennett K; McGreevy C; Williams D
    Eur J Clin Pharmacol; 2013 Jul; 69(7):1467-75. PubMed ID: 23443628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic rates and treatment of dementia before and after launch of a national dementia policy: an observational study using English national databases.
    Mukadam N; Livingston G; Rantell K; Rickman S
    BMJ Open; 2014 Jan; 4(1):e004119. PubMed ID: 24413352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008.
    Lazzeroni LC; Halbauer JD; Ashford JW; Noda A; Hernandez B; Azor V; Hozack N; Hasson N; Henderson VW; Yesavage JA; Tinklenberg JR
    J Alzheimers Dis; 2013; 36(4):791-8. PubMed ID: 23703151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
    Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews.
    Laver K; Dyer S; Whitehead C; Clemson L; Crotty M
    BMJ Open; 2016 Apr; 6(4):e010767. PubMed ID: 27121704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
    Hartmann S; Möbius HJ
    Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.
    Maxwell CJ; Vu M; Hogan DB; Patten SB; Jantzi M; Kergoat MJ; Jetté N; Bronskill SE; Heckman G; Hirdes JP
    Drugs Aging; 2013 Jul; 30(7):569-85. PubMed ID: 23605786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia.
    Parsons C; Briesacher BA; Givens JL; Chen Y; Tjia J
    J Am Geriatr Soc; 2011 Jul; 59(7):1253-9. PubMed ID: 21668913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.